Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.74 |
| ▸ | TSHR | P16473 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | TP53 | P04637 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.74 |
| ▸ | PPARG | P37231 | 1/20 | 0.74 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.46 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3231128 | 0.97 | ALDH1A1 (0.80) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL6758041 | 0.93 | TSHR (0.65) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL162686 | 0.93 | ALDH1A1 (0.72) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL22106551 | 0.91 | TSHR (0.70) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL20390747 | 0.91 | ALDH1A1 (0.90) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL22688280 | 0.90 | MEN1 (0.60) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL13190987 | 0.89 | ALDH1A1 (0.76) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL22203228 | 0.88 | MEN1 (0.62) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL25576467 | 0.88 | MEN1 (0.58) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL12387479 | 0.88 | TSHR (0.79) | ALDH1A1TSHRMEN1KMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8333356-A | — | — | None | — | — | JP | disclosed |
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| US-20230174774-A1 | RESIN COMPOSITION AND ELECTRONIC COMPONENT | KYOCERA CORPORATION (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| EP-1778636-B1 | OXIME ESTER PHOTOINITIATORS | CIBA SC HOLDING AG (CH) | 2007-12-19 | — | — | EP | disclosed |
| EP-1794240-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-06-13 | — | — | EP | disclosed |
| US-20070129502-A1 | Polyphenylene ethers; improved chemical resistance, dielectric, low water-absorption, heat resistance, flame retardance, and mechanical properties; laminates | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20070129502-A1 | Polyphenylene ethers; improved chemical resistance, dielectric, low water-absorption, heat resistance, flame retardance, and mechanical properties; laminates | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20060241259-A1 | Oxime ester photoinitiators with heteroaromatic groups | CIBA CORPORATION | 2006-10-26 | — | — | US | disclosed |
| WO-2006037728-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-13 | — | — | WO | disclosed |
| EP-1316555-B1 | Episulfide compound, method for producing the same and optical product comprising the same | HOYA CORP (JP) | 2005-02-02 | — | — | EP | disclosed |
| US-6696540-B2 | HIGH REFRACTIVE INDEX | HOYA CORPORATION (JP) | 2004-02-24 | — | — | US | disclosed |
| US-20030144431-A1 | Episulfide compound, method for producing the same and optical product comprising the same | HOYA CORPORATION | 2003-07-31 | — | — | US | disclosed |
| JP-H08333356-A | NEW GLYCIDYL COMPOUND, ITS PRODUCTION AND CURABLE COMPOSITION CONTAINING THE SAME COMPOUND | ASAHI CHIBA KK | 1996-12-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | ALDH1A1 823/4885TSHR 528/4885MEN1 2400/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | ALDH1A1 964/4885TSHR 2202/4885MEN1 4834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.